Cook sells pharmaceutical unit for $200 million
This article was originally published in Clinica
Executive Summary
Cook Group is to sell the assets of its Cook Pharmaceuticals Solutions division to Baxter Healthcare for around $200 million in cash and stock. The move will allow Cook Group to focus on its core business of minimally invasive medical devices for interventional and therapeutic procedures. Cook's products include stents and stent grafts, catheters, wire guides and tissue-engineered medical biomaterials.